Immune dysfunction in diabetes-prone BB rats. Interleukin 2 production and other mitogen-induced responses are suppressed by activated macrophages.
Open Access
- 1 February 1984
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 159 (2) , 463-478
- https://doi.org/10.1084/jem.159.2.463
Abstract
Spleen cells of diabetes-prone BB Wistar rats generated excessively low proliferative responses, and interleukin 2 (IL-2) levels in response to T-dependent mitogens. This abnormality was not due solely to abnormal T cell numbers since: addition of BB spleen cells or BB splenic macrophages to normal major histocompatibility complex (MHC)-matched Wistar Furth (WF) spleen cells resulted in severe suppression of concanavalin A (ConA), phytohemagglutinin- and pokeweed mitogen-mediated proliferation, and IL-2 production; macrophage depletion from BB spleen cells, but not B cell or T cell depletion, removed completely the suppressive effects of BB cells on WF cells; macrophage depletion greatly enhanced the response of BB lymphocytes to T-dependent mitogens. Although suppressor macrophages could also be found in the spleen of WF control rats they were present in much smaller numbers than in the spleen of BB rats. The suppressive effect of BB macrophages was partially reduced by addition of the prostaglandin synthetase inhibitor indomethacin to cultures. Indomethacin (but not catalase or PMA [phorbol myristate acetate]) considerably augmented IL-2 secretion of ConA-stimulated BB spleen cells, but had little effect on WF spleen cells. Prostaglandins E1 and E2 (PGE1 and PGE2) suppressed IL-2 production. While IL-2 secretion was severely depressed in BB rats, unstimulated and lipopolysaccharide (LPS)-stimulated IL-1 secretion by splenic macrophages was normal. BB macrophages did not inactivate IL-2. Low IL-2 production and macrophage-mediated suppression were features of all BB rats tested.This publication has 42 references indexed in Scilit:
- Virus-induced Diabetes in Autoimmune New Zealand MiceDiabetes, 1983
- Macrophage-mediated suppression. I. Evidence for participation of both hdyrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation.The Journal of Immunology, 1980
- SUPPRESSOR MONOCYTES IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - EVIDENCE OF SUPPRESSOR ACTIVITY ASSOCIATED WITH A CELL-FREE SOLUBLE PRODUCT OF MONOCYTES1980
- Malignant lymphoma in spontaneously diabetic rats.1979
- SIGNAL REQUIREMENTS FOR LYMPHOCYTE-T ACTIVATION .1. REPLACEMENT OF MACROPHAGE FUNCTION WITH PHORBOL MYRISTIC ACETATE1979
- T Cell Growth Factor: Parameters of Production and a Quantitative Microassay for ActivityThe Journal of Immunology, 1978
- "Panning" for lymphocytes: a method for cell selection.Proceedings of the National Academy of Sciences, 1978
- Responses of Fractionated Cells from Patients with Systemic Lupus Erythematosus and Normals to Plant Mitogen: Evidence for a Suppressor Population of MonocytesExperimental Biology and Medicine, 1978
- Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell.The Journal of Experimental Medicine, 1977
- Separation of mouse spleen cells by passage through columns of sephadex G-10Journal of Immunological Methods, 1974